Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delgocitinib in Facial Vitiligo
NCT07820098Phase 2Active, not recruiting
- Start
- Apr 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
A Phase 2 trial of delgocitinib in Vitiligo. Started Apr 2026; status: active, not recruiting.
02
Drugs
delgocitinib
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT07820098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07820098.